Abstract
Our purpose was obtaining and characterizing a complex composite system with multifunctional role: bone graft material and hyperthermia generator necessary for bone cancer therapy. The designed system was a magnetite enriched collagen/hydroxyapatite composite material, obtained by a co-precipitation method. Due to the applied electromagnetic field the magnetite will induce hyperthermia and cause tumoral cell apoptosis. The complex bone graft system was characterised by XRD, FTIR and SEM, while the hyperthermia was quantify by measuring the temperature increase due to the applied alternative electromagnetical field.
Similar content being viewed by others
References
Brahler M, Georgieva R, Buske N, Muller A, Muller S, Pinkernelle J, et al. Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. Nano Lett. 2006;6(11):2505–9.
Lin CY, Ho KC. Synthesis of superparamagnetic magnetite nanoparticles for thermoresponsive drug delivery. Nanotechnology. 2007;2:405–8.
Yang J, Lee H, Hyung W, Park S-B, Haam S. Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics. J Microencapsul. 2006;23(2):203–12.
Matsuoka F, Shinkai M, Honda H, Kubo T, Sugita T, Kobayashi T. Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. Biomagn Res Technol. 2004;2(1):3.
Orentas R, Hodge JW, Johnson BD, editors. Cancer vaccines and tumor immunity. New York: Wiley; 2008.
Li BQ, Jia DC, Zhou Y, Hu QL, Cai W. Magnetic hydroxyapatite/chitosan nanocomposites via in situ hybridization strategy. Bioceramics. 2007;330–332(Pts 1–2):357–60.
Wu J, Hu QL, Chen FP, Li BQ, Shen JC. Study of the mechanical property of magnetite/hydroxyapatite/chitosan nano-composite. Bioceramics. 2007;330–332(Pts 1–2):435–8.
Cui W, Hu QL, Wu J, Li BQ, Shen JC. Preparation and characterization of magnetite/hydroxyapatite/chitosan nanocomposite by in situ compositing method. J Appl Polym Sci. 2008;109(4):2081–8.
Murakami S, Hosono T, Jeyadevan B, Kamitakahara M, Ioku K. Hydrothermal synthesis of magnetite/hydroxyapatite composite material for hyperthermia therapy for bone cancer. J Ceram Soc Jpn. 2008;116(1357):950–4.
Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Le Garrec D, Chenite A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm. 2004;57(1):53–63.
Yan XL, Gemeinhart RA. Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles. J Control Release. 2005;106(1–2):198–208.
Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localised cancer therapy. J Control Release. 2008;126(3):205–16.
Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RSR. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. J Control Release. 2005;105(3):185–98.
Miyazaki T, Yomota C, Okada S. Development and release characterization of hyaluronan-doxycycline gels based on metal coordination. J Control Release. 2001;76(3):337–47.
Konishi M, Tabata Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release. 2005;103(1):7–19.
Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release. 2008;127(1):41–9.
Harashima H, Iida S, Urakami Y, Tsuchihashi M, Kiwada H. Optimization of anti-tumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. J Control Release. 1999;61(1–2):93–106.
Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B, et al. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Release. 2007;121(1–2):110–23.
Wang JP, Takayama K, Nagai T, Maitani Y. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm. 2003;251(1–2):13–21.
Netz DJA, Sepulveda P, Pandolfelli VC, Spadaro ACC, Alencastre JB, Bentley MVLB, et al. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm. 2001;213(1–2):117–25.
Xu R, Ma J, Sun XC, Chen ZP, Jiang XL, Guo ZR, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. 2009;19(8):1031–4.
Melnikov OV, Gorbenko OY, Markelova MN, Kaul AR, Atsarkin VA, Demidov VV, et al. Ag-doped manganite nanoparticles: new materials for temperature-controlled medical hyperthermia. J Biomed Mater Res A. 2009;91A(4):1048–55.
Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004;11(3):169–83.
Ficai A, Andronescu E, Ghitulica C, Voicu G, Trandafir V, Manzu D, et al. Collagen/hydroxyapatite interactions in composite biomaterials. Mater Plast. 2009;46(1):11–5.
Li Y, Asadi A, Monroe MR, Douglas EP. pH effects on collagen fibrillogenesis in vitro: electrostatic interactions and phosphate binding. Mater Sci Eng C. 2009;29(5):1643–9.
Ficai A, Andronescu E, Voicu G, Ghitulica C, Ficai D. The influence of collagen support and ionic species on the morphology of collagen/hydroxyapatite composite materials. Mater Charact. 2010;61:402–7. doi:10.1016/j.matchar.2010.01.003.
Ficai A, Andronescu E, Trandafir V, Ghitulica C, Voicu G. Collagen/hydroxyapatite composite obtained by electric field orientation. Mater Lett. 2010;64(4):541–4.
Acknowledgements
We are gratefully thanks to Chem. Madalina ALBU to provide us the collagen gel. This work was partially supported by Romanian National Authority for Scientific Research through project 72_198/2008.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andronescu, E., Ficai, M., Voicu, G. et al. Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment. J Mater Sci: Mater Med 21, 2237–2242 (2010). https://doi.org/10.1007/s10856-010-4076-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-010-4076-7